NCT05184231撤回不适用
Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- Ipsen
- 主要终点
- Overall patient satisfaction with SSA treatment.
研究概览
简要总结
The purpose of the protocol is to achieve an in-depth understanding of the current satisfaction status of somatostatin analogue (SSA) treatment for acromegaly through patient and physician surveys.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •For Patients:
- •Age 18 years or older
- •Diagnosed with acromegaly
- •Receiving current SSA injections for acromegaly treatment for at least 3 months
- •Signed electronic Informed Consent Form (eICF)
- •For Physicians:
- •Licensed endocrinologists or neurosurgeons
- •Having prescribed SSAs for at least five patients with acromegaly in the past 6 months
- •Signed eICF
排除标准
- •Patients will not be included in the survey if they meet any of the following criteria:
- •Patients who are not able to successfully complete the questionnaire independently
- •Pregnant patients
结局指标
主要结局
Overall patient satisfaction with SSA treatment.
时间窗: During the whole study period (approximately 3 months).
To be assessed by four levels of satisfaction including very satisfied, satisfied, dissatisfied, and very dissatisfied
次要结局
- Patient satisfaction with symptom control of SSA treatment(During the whole study period (approximately 3 months).)
- Patient satisfaction with frequency of administration of SSA treatment(During the whole study period (approximately 3 months).)
- Patient satisfaction with injection site reactions of SSA treatment(During the whole study period (approximately 3 months).)
- Physician satisfaction with symptom control of SSA treatment(During the whole study period (approximately 3 months).)
- Physician satisfaction with convenience of administration of SSA treatment(During the whole study period (approximately 3 months).)
- Patient satisfaction with convenience of administration of SSA treatment(During the whole study period (approximately 3 months).)
- Physician satisfaction with frequency of administration of SSA treatment(During the whole study period (approximately 3 months).)
- Physician satisfaction with adverse reactions to SSA treatment(During the whole study period (approximately 3 months).)
- Patient satisfaction with mode of administration of SSA treatment(During the whole study period (approximately 3 months).)
- Patient satisfaction with adverse reactions to SSA treatment(During the whole study period (approximately 3 months).)
- Physician satisfaction with injection site reactions of SSA treatment(During the whole study period (approximately 3 months).)
- Aspects of patient concern before initiating SSA treatment(During the whole study period (approximately 3 months).)
- Physician overall satisfaction with SSA treatment.(During the whole study period (approximately 3 months).)
- Physician satisfaction with mode of administration of SSA treatment(During the whole study period (approximately 3 months).)
- Aspects of physician concern before prescribing SSA treatment(During the whole study period (approximately 3 months).)
- Overall patient satisfaction with SSA treatment: satisfied versus dissatisfied with their SSA treatment.(During the whole study period (approximately 3 months).)
研究者
相似试验
已完成
不适用
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering SurgeryBreast SurgeryBreast ReconstructionBreast ReductionBreast AugmentationBreast CancerNCT00605670Memorial Sloan Kettering Cancer Center722
已完成
不适用
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of LifePsoriasis VulgarisNCT01982552LEO Pharma147
已完成
不适用
Evaluating Patient and Caregiver Satisfaction with the Informed Consent Process in SurgeryInformed ConsentPatient and Caregiver SatisfactionNCT06746207Maharajgunj Medical Campus384
尚未招募
不适用
Switch From Oral Therapy to Long-acting Injectable Cabotegravir + RilpivirinePatient SatisfactionPatient PreferenceQuality of LifeAcceptability of Health CareNCT05835635Pontificia Universidad Catolica de Chile50
已完成
不适用
Patient Surveys - What Patients WantPatient SurveyNCT03698097University Hospital, Basel, Switzerland745